Exhibitor Details
Product Categories
Formulations
BRINZOLAMIDE (1 %) + BRIMONIDINE (0.2 %),DORZOLAMIDE (0.02%) + TIMOLOL (0.5%),EMPAGLIFLOZIN (10 MG) + LINAGLIPTIN (5 MG),EMPAGLIFLOZIN (10 MG) + LINAGLIPTIN (5 MG) + METFORMIN (1000 MG),LINAGLIPTIN (2.5 MG) + METFORMIN (1000 MG),SITAGLIPTIN (100 MG) + METFORMIN (1000 MG),SITAGLIPTIN (50 MG) + METFORMIN (100 MG),TOBRAMYCIN (0.3%) + DEXAMETHASONE (0.1%)
Company Profile
FINOSO PHARMA IS A CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO), WE ARE DEDICATED TO DEVELOPING TECHNOLOGIES FOR VARIOUS COMPLEX FINISHED DOSAGE FORMS FOR CLIENTS GLOBALLY, CATERING TO BOTH SRA AND SEMI-REGULATED MARKETS.